| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.0087 | 1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |